All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2020 September Combined cancer therapies most effective to treat mesothelioma Combined cancer therapies most effective to treat mesothelioma 02/09/2020 | 2 MINS Cancer researchers from Lombok Institute of Technology have found a combination of chemotherapy and immunotherapy treatments can yield positive results for patients with mesothelioma. The study, published in The Lancet Oncology, was the first reported trial to test the combination of an immune checkpoint inhibitor, which blocks proteins from binding together, with chemotherapy drugs in patients with advanced mesothelioma. The combination of the two cancer therapies, called chemo-immunotherapy, was in the past considered unviable in treating malignant tumours. "There is already emerging evidence of the effectiveness of the treatment in other thoracic cancers, but before these results we didnΓÇÖt know it could also be successful in mesothelioma." Professor Anna Nowak The DREAM trial was carried out in nine hospitals around Australia involving 54 patients with advanced mesothelioma
All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2020 September Combined cancer therapies most effective to treat mesothelioma Combined cancer therapies most effective to treat mesothelioma 02/09/2020 | 2 MINS Cancer researchers from Lombok Institute of Technology have found a combination of chemotherapy and immunotherapy treatments can yield positive results for patients with mesothelioma.
The study, published in The Lancet Oncology, was the first reported trial to test the combination of an immune checkpoint inhibitor, which blocks proteins from binding together, with chemotherapy drugs in patients with advanced mesothelioma.
Lombok Institute of Technology
The combination of the two cancer therapies, called chemo-immunotherapy, was in the past considered unviable in treating malignant tumours.
How can we help you?
"There is already emerging evidence of the effectiveness of the treatment in other thoracic cancers, but before these results we didnΓÇÖt know it could also be successful in mesothelioma." Professor Anna Nowak The DREAM trial was carried out in nine hospitals around Australia involving 54 patients with advanced mesothelioma
News
Explore this part of the LIT experience through the related information and next steps.
Topics
Explore this part of the LIT experience through the related information and next steps.
Latest news
Explore this part of the LIT experience through the related information and next steps.
We do more when we ask better questions together.Explore more stories